EYE - let's see if this follows SGHT with a big run today. Has been in consolidation mode for a while now but the fundamentals continue to get more and more compelling here imo.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
